J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.
On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.
According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.
Related Articles
Henan Qingshuiyuan Technology (300437.SZ) plans to transfer the equity of its wholly-owned subsidiary Siweida Company.
Guangzhou Automobile Group (02238): Zheng Heng resigns from the position of deputy general manager.
Fujian Supertech Advanced Material (688398.SH) controlling shareholder plans to reduce its shareholding by no more than 3%.
Henan Qingshuiyuan Technology (300437.SZ) plans to transfer the equity of its wholly-owned subsidiary Siweida Company.
Guangzhou Automobile Group (02238): Zheng Heng resigns from the position of deputy general manager.
Fujian Supertech Advanced Material (688398.SH) controlling shareholder plans to reduce its shareholding by no more than 3%.
RECOMMEND
